Robot-assisted laparoscopic nephrectomy: early outcome measures with the implementation of multimodal analgesia and intrathecal morphine via the acute pain service - Summary - MDSpire
Advertisement
Robot-assisted laparoscopic nephrectomy: early outcome measures with the implementation of multimodal analgesia and intrathecal morphine via the acute pain service
To evaluate the association of an APS-driven multimodal analgesia protocol, including preoperative intrathecal morphine (ITM), with postoperative opioid use and other relevant outcomes in patients undergoing robot-assisted nephrectomy.
Key Findings:
Implementation of APS-driven multimodal analgesia with ITM was associated with decreased median 24-h opioid consumption (specify exact reduction).
Secondary outcomes showed reduced opioid use during 24–48 h and 48–72 h postoperative periods.
Length of hospital stay was also evaluated but specific results were not detailed.
Interpretation:
The study suggests that a multimodal analgesia approach incorporating ITM can effectively reduce opioid consumption post robot-assisted nephrectomy, potentially improving patient outcomes.
Limitations:
Retrospective design may introduce bias, potentially affecting the validity of the findings.
Limited generalizability due to single-institution study.
Potential confounding factors not fully controlled despite propensity score matching.
Conclusion:
The findings support the use of APS-driven multimodal analgesia with ITM to enhance postoperative pain management and reduce opioid use in robot-assisted nephrectomy patients, highlighting the need for broader implementation in clinical practice.
by Minhthy N. Meineke, Matthew V. Losli, Jacklynn F. Sztain, Matthew W. Swisher, Wendy B. Abramson, Erin I. Martin, Timothy J. Furnish, Amirali Salmasi, Ithaar H. Derweesh, Rodney A. Gabriel, Engy T. Said
